dactinomycin has been researched along with ozagrel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Goldman, G; Hechtman, HB; Klausner, JM; Shepro, D; Valeri, CR; Welbourn, R | 1 |
2 other study(ies) available for dactinomycin and ozagrel
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Thromboxane mediates diapedesis after ischemia by activation of neutrophil adhesion receptors interacting with basally expressed intercellular adhesion molecule-1.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Capillaries; CD18 Antigens; Cell Adhesion Molecules; Dactinomycin; Endothelium, Vascular; Fatty Acids, Unsaturated; Hydrazines; Intercellular Adhesion Molecule-1; Ischemia; Male; Methacrylates; Muscles; Neutrophils; Rabbits; Receptors, Leukocyte-Adhesion; Reference Values; Regional Blood Flow; Reperfusion; Skin; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1991 |